Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9129 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Albert E Zhou und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: CREST Syndrome, Dermatitis, Heterocyclic Compounds, 3-Ring, Janus Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Zhou, A. E., Ravi, S., Murphy, M., Lu, J., & Ferenczi, K. (2025). Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9129
Vancouver
Zhou AE, Ravi S, Murphy M, Lu J, Ferenczi K. Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9129
BibTeX
@article{Zhou2025,
author = {Zhou, Albert E and Ravi, Sowmya and Murphy, Michael and Lu, Jun and Ferenczi, Katalin},
title = {Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9129}
}
EUVIMED